id: roux_en_y_gastric_bypass_surgery_to_cirrhosis_development
name: Roux-en-Y Gastric Bypass Surgery â†’ Development of Cirrhosis
from_node:
  node_id: roux_en_y_gastric_bypass_surgery
  node_name: Roux-en-Y Gastric Bypass Surgery
to_node:
  node_id: cirrhosis_development
  node_name: Development of Cirrhosis
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: RYGB surgery alters hepatic metabolism and alcohol processing due to anatomical
  changes in gastrointestinal tract'
- 'Step 2: Altered absorption patterns lead to different alcohol pharmacokinetics
  and potentially higher peak blood alcohol concentrations'
- 'Step 3: Enhanced hepatotoxic effects and metabolic stress accelerate liver fibrosis
  progression'
- 'Step 4: Faster progression from alcohol-associated hepatitis to cirrhosis occurs
  in RYGB patients'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Chimaobi Anugwom et al. 2023. "Lower survival and higher rates
    of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated
    hepatitis." *BMJ Open Gastroenterology*. https://doi.org/10.1136/bmjgast-2022-001083
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.354025'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: baseline_disease_severity
  direction: strengthens
  strength: strong
  description: RYGB patients had higher baseline MELD-Na scores suggesting more advanced
    disease at presentation
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/roux_en_y_gastric_bypass_surgery_to_cirrhosis_development.yaml
_category: healthcare_access
